TREA

88779673

Follow

Information

  • Trademark
  • 88779673
  • Serial Number
    88779673
  • Registration Number
    6135446
  • Filing Date
    January 30, 2020
    5 years ago
  • Registration Date
    August 25, 2020
    4 years ago
  • Transaction Date
    October 24, 2024
    4 months ago
  • Status Date
    August 25, 2020
    4 years ago
  • Published for Opposition Date
    June 09, 2020
    4 years ago
  • Location Date
    August 25, 2020
    4 years ago
  • First Use Anywhere Date
    November 25, 2019
    5 years ago
  • First Use In Commerce Date
    November 25, 2019
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    COUGHLAN, REBECCA
  • Attorney Docket Number
    90125.00150
    Attorney Name
    David S. Kerr
    Law Office Assigned Location Code
    M40
  • Owners
Information
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of a series of circular shapes that form a larger circle having the outline of a hand at the center.
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, acellular vaccines, protein-based vaccines, conjugated vaccines, and vaccines generated in an in vitro cell-free expression system; Research and development in the field of bioinformatics and production of proteins in cell-free expression systems for the development of vaccines; Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use, namely, new vaccines for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics for the treatment of viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development in the field of biosynthetic pathways involved in response to viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development in the field of biosynthetic pathways and their evolution in response to viral infection, bacterial infection, fungal infection, and parasitic infestation; Research and development in the fields of bioinformatic-derived drug discovery; Research and development of software-based platforms for the identification of novel therapeutic drug compounds, namely, software-based platforms for collecting, identifying, and searching collections of natural products and biosynthesis pathways and generating a drug compound database that allows for structure guided searching to identify new therapeutic drug candidates; Services in the field of therapeutic drug discovery, namely, providing temporary use of online non-downloadable data processing software services, in the fields of pharmaceutical, biomedical, medical and clinical research and drug discovery; Services in the field of therapeutic drug discovery, namely, providing temporary use of online non-downloadable software services for the identification of novel therapeutic drug compounds, namely, providing temporary use of online non-downloadable software services for collecting, identifying, and searching collections of the biosynthetic pathways and their products and generating a drug compound database that allows for structure guided searching to identify new therapeutic drug candidates; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for therapeutic use, protein- based toxins for therapeutic use, protein-based toxins generated in an in vitro cell-free expression system for therapeutic and medical research uses; Research and development in the field of bioinformatics and production of protein-based toxins having therapeutic applications; Research and development of new toxin compounds for therapeutic use, namely, new protein-based toxins for therapeutic use; Research and development of pharmaceuticals, therapeutics, and biologics, namely, toxins for diagnostic use, protein-based toxins for diagnostic use, protein-based toxins generated in an in vitro cell-free expression system for diagnostic and medical research uses
Case File Event Statements
  • 2/3/2020 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/5/2020 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/6/2020 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 4/20/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/22/2020 - 4 years ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/22/2020 - 4 years ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/22/2020 - 4 years ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/22/2020 - 4 years ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/27/2020 - 4 years ago
    9 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/5/2020 - 4 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 6/9/2020 - 4 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/9/2020 - 4 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/25/2020 - 4 years ago
    14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/9/2020 - 4 years ago
    15 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 10/23/2024 - 4 months ago
    16 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 5/20/2020 - 4 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP